Data as of Sep 26, 2026 · Based on 4,029,442 AI responses across 13,338 prompts · See how Parse measures this
OCT Clinical Trials is a European CRO formed after merging with Palleos Healthcare, delivering full‑service support for clinical trials (Phase I–IV and BE) including study design, regulatory consulting, data management, biostatistics, pharmacovigilance, project management, and clinical supply. It operates in 21 countries with access to about 2,100 leading research sites and has completed over 300 studies across 29 therapeutic areas, with a focus on oncology as well as gastroenterology, neurology, rheumatology, and infectious diseases. The company emphasizes rapid recruitment, feasibility services, EMA/FDA‑acceptable data, and is a member of the European CRO Federation.
The market map · 5 of 100 labelled
Clinical Trial Management Software →Where OCT Clinical Trials ranks in AI
Veeva Vault CTMS is the top alternative to
OCT Clinical Trials
No contexts measured yet.
Excerpts where OCT Clinical Trials appeared in the AI's answer
OCT Clinical Trials — A prominent regional specialist explicitly focused on Eastern Europe and CIS countries, recognized for high patient recruitment rates and extensive oncology trial experience.
OCT Clinical Trials : A prominent regional leader explicitly focused on Eastern Europe, Central Eastern Europe (CEE), and the CIS countries.